Drawing for HIZENTRA GODISC

USPTO serial 98175805

HIZENTRA GODISC

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
Examiner
PARKS, KIMBERLY L
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with HIZENTRA GODISC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST. NWSUITE 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of immunodeficiency disorders; Pharmaceutical preparations for the treatment of chronic inflammatory demyelinating polyneuropathy and primary immunodeficiency; pharmaceutical preparations in the nature of intravenous immunoglobulins for use in the treatment of immunodeficiency disorders and in immune replacement therapyACTIVE
010Surgical and medical apparatus and instruments for subcutaneous treatment, namely, for the administration of subcutaneous therapy; Medical devices for the administration of subcutaneous therapy for use in treating immunodeficiency disorders; Surgical instruments for use in the administration of subcutaneous medicine; medical instruments for use in the administration of subcutaneous infusion of medicine; Medical apparatus and instruments for use in subcutaneous medical procedures; Medical devices for the administration of subcutaneous therapy, namely, medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatmentACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2026EX4GSOU EXTENSION 4 GRANTED
Jun 30, 2026EXT4SOU EXTENSION 4 FILED
Jun 30, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 3, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 2, 2026EX3GSOU EXTENSION 3 GRANTED
Jan 2, 2026EXT3SOU EXTENSION 3 FILED
Jan 2, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 30, 2025EX2GSOU EXTENSION 2 GRANTED
Jun 30, 2025EXT2SOU EXTENSION 2 FILED
Jun 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2024EX1GSOU EXTENSION 1 GRANTED
Dec 30, 2024EXT1SOU EXTENSION 1 FILED
Dec 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2024DOCKASSIGNED TO EXAMINER
Oct 2, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance